Ophthalmology

1-16 of 99

Outcomes for PDR Patients LTFU for at Least 1 Year
Outcomes for PDR Patients LTFU for at Least 1 Year
Ophthalmology
Outcomes for PDR Patients LTFU for at Least 1 Year
- Kyle Davis Kovacs, MD
- Matt Starr, MD
- Nita Valikodath, MD, MS
Examining Therapeutic Timing in RVO-Related Macular Edema
Examining Therapeutic Timing in RVO-Related Macular Edema
Eye on Ocular Health
Examining Therapeutic Timing in RVO-Related Macular Edema
Real-World Switching to Faricimab from Legacy Anti-VEGFs in Wet AMD
Real-World Switching to Faricimab from Legacy Anti-VEGFs in Wet AMD
Ophthalmology
Real-World Switching to Faricimab from Legacy Anti-VEGFs in Wet AMD
- Maria H. Berrocal, MD
- Lejla Vajzovic, MD, FASRS
How Anti-VEGF Compares with Steroids in Retinal Vein Occlusion
How Anti-VEGF Compares with Steroids in Retinal Vein Occlusion
Eye on Ocular Health
How Anti-VEGF Compares with Steroids in Retinal Vein Occlusion
- Ryan Quigley
Overcoming Cultural and Communication Disconnects, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
Overcoming Cultural and Communication Disconnects, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
CME/CE
Overcoming Cultural and Communication Disconnects, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
0.25 credits
- David Chin Yee, MD, FASRS
0.25 credits
Patient at High Risk of Loss to Follow-Up, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
Patient at High Risk of Loss to Follow-Up, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
CME/CE
Patient at High Risk of Loss to Follow-Up, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
0.25 credits
- Deepak Sambhara, MD
0.25 credits
A Case of Missed Diagnosis, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
A Case of Missed Diagnosis, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
CME/CE
A Case of Missed Diagnosis, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
0.25 credits
- Esther Lee Kim, MD
0.25 credits
It Takes a Village, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
It Takes a Village, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
CME/CE
It Takes a Village, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
0.25 credits
- David Eichenbaum, MD
0.25 credits
Diagnosis Delays in Stargardt Disease
Diagnosis Delays in Stargardt Disease
Ophthalmology
Diagnosis Delays in Stargardt Disease
- Alexis Warren, MD
- Jesse Sengillo, MD
- Sruthi Arepalli, MD
Suprachoroidal Steroids in Patients With a History of Glaucoma and Ocular Hypertension
Suprachoroidal Steroids in Patients With a History of Glaucoma and Ocular Hypertension
Ophthalmology
Suprachoroidal Steroids in Patients With a History of Glaucoma and Ocular Hypertension
- Maria H. Berrocal, MD
- Danny Mammo, MD
Anti-VEGF for Proliferative Sickle Cell Retinopathy
Anti-VEGF for Proliferative Sickle Cell Retinopathy
Clinical Minute Retina
Anti-VEGF for Proliferative Sickle Cell Retinopathy
- Maria H. Berrocal, MD
- Jennifer Lim, MD
Practice Efficiency and Innovation
Practice Efficiency and Innovation
Modern Optometry
Practice Efficiency and Innovation
- Jacob Lang
Elevating Clinical Efficiency
Elevating Clinical Efficiency
Modern Optometry
Elevating Clinical Efficiency
- Diana Chu
Redefining The Cash-Pay Model in Modern Optometric Practice
Redefining The Cash-Pay Model in Modern Optometric Practice
Modern Optometry
Redefining The Cash-Pay Model in Modern Optometric Practice
- Jason E. Compton, OD, FAAO
Tailored Treatment in Retinal Disease: Using Biomarkers to Guide Anti-VEGF Therapy
Tailored Treatment in Retinal Disease: Using Biomarkers to Guide Anti-VEGF Therapy
Eye on Ocular Health
Tailored Treatment in Retinal Disease: Using Biomarkers to Guide Anti-VEGF Therapy
- Jennifer Caudle, DO, FACOFP
- Michael Javaheri, MD, MSc, FASRS
AI for Ocular Oncology
AI for Ocular Oncology
Clinical Minute Retina
AI for Ocular Oncology
- Maria H. Berrocal, MD
- Zelia Correa, MD, PhD

1/6

1-16 of 99

Title

Share on ReachMD